Boston Scientific touts safety, effectiveness in Rhythmia mapping system study
This study was the first to perform systematic data collection on a range of arrhythmia types using the Rhythmia mapping system. Importantly, validation mapping allowed for precise views of therapy success and the identification of new areas in the heart requiring additional ablations that would have otherwise gone untreated,” principal investigator Dr. Gerhard Hindricks of Germany’s Leipzig University Heart Center said in a prepared statement. Results from the trial indicated an acute success rate of 95.7%, Boston Scientific said, with the Rhythmia mapping system allowing physicians to assess th...
Source: Mass Device - March 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Imaging Boston Scientific Source Type: news
New Expert Statement on Arrhythmias and Cognitive Function New Expert Statement on Arrhythmias and Cognitive Function
Anticoagulation for patients with atrial fibrillation is at the core of the expert consensus document, which also highlights the enormous need for further research in this area.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Medtronic touts one-year data on Arctic Front Advance cryoballoon
Medtronic (NYSE:MDT) today touted results from a clinical trial of its Arctic Front Advance cryoballoon for treating atrial fibrillation. Results from the 130-patient Cryo4Persistent AF trial, presented at the annual meeting of the European Heart Rhythm Assn. in Barcelona, is an open-label, single-arm study with a primary outcome of single-procedure success at 12 months. Single-procedure success is defined as “absence of adjudicated AF/atrial flutter/atrial tachyarrhythmias” of 30 or more seconds, clocked after a 90-day blanking period following the cryoablation procedure, according to ClinicalTrials.gov. ...
Source: Mass Device - March 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Cardiac Rhythm Management European Heart Rhythm Assn. Medtronic Source Type: news
Study finds the heart can terminate atrial fibrillation itself after local gene therapy
(European Society of Cardiology) The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 19, 2018 Category: International Medicine & Public Health Source Type: news
A Diagnostic Dilemma: Sometimes You ’ ll Never Know
Patient Presentation A 9-year-old male came to clinic with a 1 month history of painful joint swelling. One month ago he started having right ankle pain that was intermittent but consistent. One day ago his right wrist, right ankle and bilateral knees had some swelling but no erythema or warmth. He says that he has pain in them when he moves but not when he is resting and he denies any joint stiffness or gelling. He also had 1-2 days of multiple red skin lesions on his extremities and trunk, not overlying the affected joints. The skin lesions do not come and go and do not itch. They are mainly discrete circular lesions wi...
Source: PediatricEducation.org - March 19, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Stroke prevention drugs may help reduce dementia risk for atrial fibrillation patients
(European Society of Cardiology) Patients with atrial fibrillation could reduce the risk of dementia by taking stroke prevention medications, according to recommendations published online today in EP Europace1, a European Society of Cardiology journal, and presented at EHRA 2018.2 The international consensus document was also published in HeartRhythm, the official journal of the Heart Rhythm Society (HRS), and Journal of Arrhythmia, the official journal of the Japanese Heart Rhythm Society (JHRS) and the Asia Pacific Heart Rhythm Society (APHRS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2018 Category: International Medicine & Public Health Source Type: news
AliveCor touts high precision AF detection, AI-powered hyperkalemia detection in KardiaBand studies
AliveCor this week announced results from two studies of its Apple (NSDQ:AAPL) smartphone-connected KardiaBand personal electrocardiogram device, touting the bands ability to detect atrial fibrillation and its ability to detect high potassium levels. Results from the studies, which were presented this week at the American College of Cardiology’s 67th Annual Scientific Session, provide more support to the usefulness and validity of the band as a cardiovascular health monitor, AliveCor CEO Vic Gundotra told MassDevice.com in an interview. “Doctors will read healthcare news, but until once it’s bee...
Source: Mass Device - March 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Patient Monitoring AliveCor Source Type: news
An Alarming Trend
Alarms have gotten much more attention in the last few years as a patient safety intervention, and they seem to have far more opponents than proponents. I ’m not talking about alarms that alert an intensive care unit nurse of a critically low oxygen saturation or dangerous arrhythmia. I am referring to devices like bed alarms, tab alarms, pressure sensor pads, chair alarms, and the like. As a fall and injury reduction measure, alarms have essentiall y become the new equivalent of physical restraints or antipsychotics in the way they have been demonized. (Source: Caring for the Ages)
Source: Caring for the Ages - March 1, 2018 Category: Health Management Authors: Karl Steinberg Tags: on my mind Source Type: news
Cardiva Medical adds $11m for vascular closure devices
Cardiva Medical said yesterday that it added another $11 million to a funding round it closed last year at $30 million to continue the commercialization of its Vascade vascular closure device. Existing debt and equity investors participated, including PTV Healthcare Capital, Canepa Healthcare and affiliates of Luther King Capital Mgmt., the Santa Clara, Calif.-based company said. In March 2017 Cardiva said it had put a bow around the $30 million round for Vascade, which won 510(k) clearance from the FDA in February 2013. Yesterday the company said the latest infusion will also go toward its Ambulate investigation...
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Vascular Wall Street Beat Cardiva Medical Inc. Source Type: news
Atrial Fib After Bypass Packs Long-term Deleterious Punch Atrial Fib After Bypass Packs Long-term Deleterious Punch
The arrhythmia was found almost exclusively in patients treated with bypass surgery and was associated with significantly worse short- and long-term outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 19, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Is FDA Getting More Cozy with AI?
The use of artificial intelligence (AI) is undoubtedly on the rise in healthcare. From fledging medtech companies to established giants like Watson IBM—many firms are riding the current AI wave. Not only are companies embracing technology, but so is FDA. Recently the agency gave approval to San Francisco-based Viz.ai’s Contact application, a type of clinical decision support software designed to analyze CT results that could notify providers of a potential stroke in their patients. “What it’s doing is comparing the imaging features in that patient with the millions of images it has been tr...
Source: MDDI - February 14, 2018 Category: Medical Devices Authors: Omar Ford Tags: Medical Device Business Digital Health Source Type: news
Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias
Sleep-disordered breathing (SDB) is associated with abnormal cardiac repolarization before coronary artery bypass graft surgery (CABG), according to new research.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Apple Wants a Bigger Bite of the Healthcare Fruit
Apple is trying to bear more fruit in healthcare with iOS healthcare applications on the iPhone and the iWatch. The company recently introduced a significant update to the Health app with the iOS 11.3 beta that allows customers to see their medical records on their iPhone. The updated Health Records section within the Health app is designed to bring together hospitals, clinics, and the existing Health app to allow users to see their medical data from multiple providers. At least 12 institutions have already agreed to make the feature available to their patients. Jordan Shlain, MD, founder of HealthLoop, will share his view...
Source: MDDI - February 2, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Source Type: news
Report: Apple in pursuit of FDA approval for iWatch-connected heart app
Apple (NSDQ:AAPL) is taking another major step into the healthcare market as it has begun to collect data it said could be used in pursuit of an FDA approval for an iOS based health application, according to a MobiHealthNews report. Participants in the study recently received prompts to sign informed consent documents that would allow the company to begin collecting data it says “will be used for FDA submission to seek approval of the investigational device,” according to MobiHealthNews. Apple isn’s seeking approval for a new device, though – it’s seeking a nod from the federal watchdog for th...
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Food & Drug Administration (FDA) Patient Monitoring Regulatory/Compliance Apple Source Type: news
Breast cancer treatments could cause heart failure
A new scientific statement issued today by the American Heart Association reveals some breast cancer therapies can increase the risk of heart arrhythmia and disease. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2018 Category: Consumer Health News Source Type: news
High blood pressure - these vitamin supplements will lower your risk of heart attacks
Vitamin D supplements could help to reverse damage to blood vessels after suffering from high blood pressure, scientists have revealed. Cardiovascular damage increases the risk of deadly cardiac arrhythmia. (Source: Daily Express - Health)
Source: Daily Express - Health - January 31, 2018 Category: Consumer Health News Source Type: news
Philips joins $9m round for remote-care co LindaCare
Digital health company LindaCare has landed an $8.7 million Series B round, with investments made by Philips (NYSE:PHG), PMV, Capricorn ICT Arkiv, Connecticut Innovations and others. The Belgium-based company said it plans to use the newly-acquired funds to accelerate its U.S. market expansion and product commercialization, as well as build out its existing patient monitoring software platform for a broader range of cardiac diseases. “This investment is a significant step for us, as it enables LindaCare to execute faster on our ambitious vision and strategy, and to take a leading market position across both...
Source: Mass Device - January 24, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Funding Roundup Patient Monitoring lindacare royalphilips Source Type: news
Cyclizine is sold in Denmark as an over-the-counter drug and has serious side effects when overdosed - Petersen K, Hjorth P.
Cyclizine is sold in Denmark as an over-the-counter drug and affects not only histaminergic but also muscarinergic, serotonergic and α-adrenergic receptors, with side effects such as respiratory depression and cardiac arrhythmias, leading to fatalities. D... (Source: SafetyLit)
Source: SafetyLit - January 18, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
An Error Message Worth Taking to Heart
In today's digital world we encounter alert messages on everything from our computers and mobile devices to our washing machines. It's not unusual to become desensitized to these messages and let them go ignored for too long. But a recent FDA safety communication serves as a reminder that some alerts warrant immediate attention, particularly when they involve a medical device that is supposed to keep you alive. The agency warned patients and caregivers that the Zoll LifeVest 4000, a wearable defibrillator used to treat life-threatening arrhythmias in adults and children at risk for sudden cardiac arrest, may fail to delive...
Source: MDDI - January 17, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Electronics Source Type: news
The Startup Caf é, the Place where Healthcare IT Decision-Makers and New Companies can Meet
17 - 19 April 2018, Berlin, Germany. Whether they develop apps that detect the early stages of cardiac arrhythmia or cybersecurity software for hospitals, startups in the healthcare IT sector are flexible, highly innovative and can make a significant contribution to digitalising the healthcare system. (Source: eHealth News EU)
Source: eHealth News EU - January 16, 2018 Category: Information Technology Tags: Featured Events Conferences and Events Source Type: news
Examining the prospective relationship between pre-disaster respiratory sinus arrhythmia and post-disaster posttraumatic stress disorder symptoms in children - Mikolajewski AJ, Scheeringa MS.
Previous studies have examined the concurrent relationship between posttraumatic stress disorder (PTSD) and a range of psychophysiological variables, including respiratory sinus arrhythmia (RSA). However, there is a lack of research examining the prospecti... (Source: SafetyLit)
Source: SafetyLit - January 16, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Mother-child coregulation of parasympathetic processes differs by child maltreatment severity and subtype - Lunkenheimer E, Busuito A, Brown KM, Skowron EA.
Parasympathetic processes appear to underlie maladaptive parent-child interactions in maltreating families, but it is unknown whether parent-child coregulation of respiratory sinus arrhythmia (RSA) differs by child maltreatment severity and subtype. RSA co... (Source: SafetyLit)
Source: SafetyLit - January 16, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Abbott launches new ablation catheter in Europe
Abbott‘s (NYSE:ABT) sensor-enabled Advisor HD Grid mapping catheter has won CE Mark approval in the European Union. The device is designed for use in any chamber of the heart during cardiac ablation. Physicians use mapping catheters to identify areas of cardiac tissue that are responsible for sending erratic electrical signals that cause arrhythmias. Abbott touted its device as having a first-of-its-kind grid configuration of electrodes that improves data collection. Linear or circular mapping catheters sometimes experience signal disruptions when the orientation of the catheter changes, Abbott explained. B...
Source: Mass Device - January 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Catheters Wall Street Beat Abbott Source Type: news
Abbott Expands Portfolio of MRI-Ready Devices
FDA gave MR-conditional labeling to two of Abbott's cardiac rhythm management (CRM) devices, a move that further boosts the company's ability to compete with its peers in the space. The Abbott Park, IL-based firm said patients who receive a Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) or a Fortify Assura implantable cardioverter defibrillator (ICD) are now able to have an MRI in the future if need be. The Quadra Assura and the Fortify Assura are two of Abbott's most widely-used high voltage devices, the company noted. In September 2016, Abbott won FDA approval for MR-conditional labeling for the...
Source: MDDI - January 3, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Regulatory and Compliance Source Type: news
The 8th Annual Alexander Awards: The Best Tox Reading of 2017
Alexander Gettler Once again, last year’s outstanding examples of long-form journalism dealing with topics related to medical toxicology were dominated by coverage of the opioid crisis, its origins and the resulting carnage. The must-read article of the year was “The Family That Built a Empire of Pain,” Patrick Radden Keefe’s massive history of the Sacklers, one of America’s richest clans, much of whose wealth comes from their ownership of Purdue Pharma and the marketing and distribution of Oxycontin. The article, which appeared in the New Yorker, notes that the clan’s patriarch, Ar...
Source: The Poison Review - January 2, 2018 Category: Toxicology Authors: Leon Gussow Tags: Medical 2017 Alexander awards opioids Purdue Pharma Sackler Source Type: news
Frailty Syndrome: A Problem in the Management of Arrhythmias Frailty Syndrome: A Problem in the Management of Arrhythmias
How prevalent is frailty in everyday practice and how does it influence the clinical management of arrhythmias?Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Survival Down With Ventricular Arrhythmia Early Post CF - LVAD
Findings from retrospective review of patients with contemporary continuous flow LVAD implantation (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 26, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pulmonology, Surgery, Journal, Source Type: news
Researchers are developing light therapy as a non-invasive, alternative treatment for disease
(Natural News) Artificial light has both its risks and benefits, but a new study shows that it may be the solution to minimally invasive, drug-free treatments. Researchers are currently developing new ways using infrared neuromodulation to treat cardiac arrhythmia (irregular heart beat), hypertension (high blood pressure), asthma, sleep apnea (suspension of breathing during sleep), diarrhea, and... (Source: NaturalNews.com)
Source: NaturalNews.com - December 18, 2017 Category: Consumer Health News Source Type: news
Zoll Medical, Myant ink next-gen LifeVest dev deal
Asahi Kasei Group company Zoll Medical said it inked an exclusive strategic multi-year deal with advanced manufacturing company Myant to develop technologies for future versions of Zoll’s LifeVest wearable defibrillator. The company’s LifeVest is designed to be worn by patients at risk of sudden cardiac death to monitor the heart continuously for abnormal heart arrhythmias and responds automatically, Zoll said. The system consists of an electrode belt and chest garment and a wrist-worn monitor. Read the whole story on our sister site, Medical Design & Outsourcing The post Zoll Medical, Myant ink next-gen Li...
Source: Mass Device - December 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Research & Development myant Zoll Medical Corp. Source Type: news
FDA approves Apple Watch's first medical device accessory
The FDA approved the KardiaBand, a mobile EKG add-on to the Apple Watch yesterday. Kardiaband is the first approved medical device to be used with the wearable tech, and can detect heart arrhythmias. (Source: the Mail online | Health)
Source: the Mail online | Health - December 1, 2017 Category: Consumer Health News Source Type: news
Spinal Elements lifts former COO Blain to the corner office | Personnel Moves November 30, 2017
Spinal Elements, previously known as Amendia, said this week it is lifting co-founder and current prez & COO Jason Blain to the position of prez & CEO, effective immediately. Prior to coming on to co-found Spinal Elements, Blain served in various roles with medtech companies Smith & Nephew (NYSE:SNN), Alphatec (NSDQ:ATEC) and NuVasive Inc. (NSDQ:NUVA). Blain is replacing Chris Fair, who will stay on as a board member with the company. “I am excited by the opportunity to lead our talented team of employees and partners and create an even more vibrant and dynamic Spinal Elements in the years ...
Source: Mass Device - November 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Abbott Alphatec Apica Cardiovascular Bovie Medical Corp. Cardiovascular Systems Inc. Dentsply Sirona Guidant Corp. Lima Corporate Medical Device Innovation Consortium MedLumics MedTech Europe Medtronic Nuv Source Type: news
Apple, Stanford launch Apple Heart Study to improve atrial fibrillation detection
The Apple Heart Study, an Apple Watch-based ResearchKit study using the heart rate sensor to look at potential arrhythmias, is launching today, the Cupertino tech giant told MobiHealthNews. (Source: mobihealthnews)
Source: mobihealthnews - November 30, 2017 Category: Information Technology Source Type: news
When Heart Disease Runs in the Family
Treatment TermsCardiomyopathy Overview Anne Goodes knew her heart beat faster than normal, but it wasn ’t until her local cardiologist detected a heart murmur that she discovered she was at risk for sudden cardiac death. At Duke, she learned the cause was hypertrophic cardiomyopathy, a common heart condition that can run in the family. Goodes soon discovered her children may need to take precaution s as well. Hero Image2017_anne_heart_596.jpg Preview Image Content Blocks Header Learning to Live with Hypertrophic Cardiomyopathy ContentHypertrophic cardiomyopathy affects the cells that make up the heart muscle,...
Source: dukehealth.org: Duke Health News - November 27, 2017 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news
New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention
Leading heart organizations provide up-to-date evidence-based recommendations on the treatment of ventricular arrhythmias and prevention of sudden cardiac death.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 21, 2017 Category: Cardiology Tags: Cardiology News Source Type: news
Can Fish Oil Help Reading?
Discussion Fats and fatty acids are essential for good human health. Saturated fats have hydrogen pairs linked to each carbon on the carbon backbone. They are solid or semi-solid at room temperature. Common examples are butter, lard, or hardened vegetable shortening. They are linked to higher cholesterol and triglycerides and only a small amount of them are recommended to be consumed in the diet. Unsaturated fats have one or more hydrogen atoms missing from the carbon backbone. They are liquid at room temperature. Monounsaturated fatty acids have one hydrogen pair that is missing from the carbon backbone. They are liq...
Source: PediatricEducation.org - November 20, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Shining a light on the nervous system to thwart disease
(Case Western Reserve University) Researchers from Case Western Reserve University School of Medicine, Vanderbilt University, and University of Pittsburgh have received a four-year, $9 million grant from the National Institutes of Health to develop enhanced infrared light technology (infrared neuromodulation) for potentially treating a variety of diseases, including cardiac arrhythmias, high and low blood pressure, asthma, sleep apnea and diarrhea, one of the leading killers of children worldwide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2017 Category: International Medicine & Public Health Source Type: news
URMC Cardiologist Receives High Honor from American Heart Association
University of Rochester Medical Center cardiologist Arthur J. Moss, M.D., whose research on cardiac arrhythmias has saved countless lives and changed the treatment of heart disease worldwide, was honored with the 2017 James B. Herrick Award at the American Heart Association ’s Scientific Sessions. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - November 13, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news
Medical News Today: What is a sinus arrhythmia?
Sinus arrhythmias commonly cause irregular heartbeats in children. In this article, we look at the symptoms, types, and outlook for sinus arrhythmia. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 12, 2017 Category: Consumer Health News Tags: Heart Disease Source Type: news
FDA warns black licorice can cause heart arrythmia
Beware of black licorice this Halloween if you're over 40, the FDA warns. Eating two ounces for two weeks or more can lower potassium levels, leading to heart arrhythmias and high blood pressure. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news
FDA: Don't OD on Black Licorice This Halloween
For people 40 and older, eating 2 ounces of black licorice a day for at least two weeks could trigger an irregular heart rhythm (arrhythmia) and other troubles, the agency warned in advance of Halloween. (Source: WebMD Health)
Source: WebMD Health - October 31, 2017 Category: Consumer Health News Source Type: news
Heart Groups Update Guidelines on Managing Ventricular Arrhythmias and Preventing Sudden Cardiac Death (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH The American Heart Association, the American College of Cardiology, and the Heart Rhythm Society have released guidelines on treating patients who have ventricular arrhythmias or otherwise are at … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 31, 2017 Category: Primary Care Source Type: news
Black Licorice: Trick or Treat?
Black licorice is an old fashioned treat that can be harmful if you eat too much. If you're 40 or older, eating 2 ounces of black licorice a day for two weeks could cause an irregular heart rhythm (arrhythmia). (Source: FDA Consumer Health Information Updates)
Source: FDA Consumer Health Information Updates - October 30, 2017 Category: Consumer Health News Source Type: news
How Genomic Research is Changing Heart Care
Genomic testing is most frequently associated with cancer testing, but this area of research is beginning to make an impact on cardiovascular care. A recent scientific statement by the American Heart Association shined a spotlight on how the expressed genome can potentially be used to diagnose diseases and predict who will develop diseases such as coronary artery disease (CAD), stroke, heart failure, and arrhythmias. According to the statement, scientists now have the ability to address disease at many levels that were inaccessible during the past century. This includes the genome, transcriptome, epigenome, proteome, metab...
Source: MDDI - October 27, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Cardiovascular Source Type: news
Study indicates home monitoring effectively detects potentially fatal fetal heart issues
(Children's Hospital Colorado) As reported in the Journal of Perinatology, researchers from Children's Hospital Colorado recently confirmed that it is feasible for at-risk pregnant women to use commercially available Doppler fetal heart rate monitors for home monitoring to detect heart arrhythmias in their developing fetuses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 25, 2017 Category: International Medicine & Public Health Source Type: news
FDA clears Acutus Medical ’ s AcQMap cardiac mapping tech
Acutus Medical said today that it won 510(k) clearance from the FDA for its AcQMap high-resolution imaging & mapping system and the 3D mapping catheter that goes by the same name. Carlsbad, Calif.-based Acutus said it plans to have the system on the U.S. market early next year. It’s designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D images of the heart chamber using ultrasound. The system won CE Mark approval in the European Union in May 2016. “This clearance will allow electrophysiologists (EPs) in the U.S. access ...
Source: Mass Device - October 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Catheters Food & Drug Administration (FDA) Regulatory/Compliance Wall Street Beat Acutus Medical Inc. Source Type: news
Acutus Medical(R) Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias
FDA clearance of the AcQMap® High Resolution Imaging and Mapping System and AcQMap® 3D Imaging and Mapping Catheter is a major milestone for Acutus Medical Clearance allows the AcQMap System to be used with commercially available cardiac ablatio... Devices, Cardiology, FDA Acutus Medical, AcQMap, AcQMap 3D, electrophysiology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2017 Category: Pharmaceuticals Source Type: news
Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.
THE CONFIRM RX ICM COMBINES ADVANCED MEDICAL DEVICE WITH THE LATEST IN MOBILE AND DIGITAL TECHNOLOGY PHYSICIANS CAN REMOTELY MONITOR THEIR PATIENTS WITH CONFIRM RX FOR EVEN THE MOST DIFFICULT TO DETECT CARDIAC ARRHYTHMIAS, INCLUDING IRREGULAR HEARTBEATS... Devices, Monitoring, Cardiology, FDA, Product Launch Abbott, Confirm Rx, Insertable Cardiac Monitor, Cardiac Monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 23, 2017 Category: Pharmaceuticals Source Type: news
Abbott wins FDA nod for Confirm Rx smartphone-connected cardiac monitor
Abbott (NYSE:ABT) said today it won FDA clearance for its Confirm Rx insertable cardiac monitor, touting it as the 1st and only smartphone compatible ICM designed to help identify cardiac arrhythmias. The Confirm Rx system includes a sensor designed to be implanted just under the skin over the chest in a minimally-invasive outpatient procedure, the company said. The newly cleared device features incorporated Bluetooth wireless technology to allow patients to connect to the device on their smartphone devices through Abbott’s myMerlin mobile application. Data collected by the device is also transmitted to the...
Source: Mass Device - October 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Food & Drug Administration (FDA) Patient Monitoring Regulatory/Compliance Abbott Source Type: news
Obesity Bigger Afib Risk Factor in Men than Women (CME/CE)
(MedPage Today) -- Men develop arrhythmia a decade earlier on average than women (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 17, 2017 Category: Cardiology Source Type: news